6/23/2014 7:29:39 AM
NEWARK, Calif., June 23, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will be a panelist at the 2014 BIO International Convention on June 25, 2014 at 4:15 pm PDT. Mr. McGlynn will participate in the panel discussion, "How International Collaboration is Accelerating the Field." This panel will showcase examples of international collaboration that are producing results or initiating new approaches to cross-border research. Under Mr. McGlynn's leadership, StemCells, Inc. launched a multi-national Phase I/II trial in spinal cord injury. The pre-clinical activities were performed in the United States and followed by the initiation of the clinical trial in Switzerland, which was subsequently expanded to both Canada and the United States. The success of these programs is a great example of how international collaboration can produce results that positively impact the lives of patients across the globe. The 2014 BIO International Convention will take place June 23-26 at the San Diego Convention Center in San Diego, CA.
Help employers find you! Check out all the jobs and post your resume.
comments powered by